|
|
||||||||
Regular Article |
Subunit1
a Laboratory of Cellular Biochemistry, Animal Resource Sciences/Veterinary Medical Sciences, University of Tokyo, Tokyo 113-8657, Japan
b Equine Research Institute, Japan Racing Association, Tochigi 320-0856, Japan
| ABSTRACT |
|---|
|
|
|---|
and ß subunits. We have previously reported that recombinant eCG has potent LH- and FSH-like activities and that the oligosaccharide at Asn56 of the
subunit plays an indispensable role in expressing LH- but not FSH-like activity. In the present study, we cloned eFSH ß subunit cDNA and expressed wild-type recombinant eFSH and a partially deglycosylated mutant FSH (eFSH
56/ß) to investigate the biological role of the oligosaccharide at Asn56 in FSH activity. The wild-type eFSH and eCG stimulated estradiol production in a dose-dependent manner in the primary cultures of rat granulosa cells, indicating that these equine gonadotropins have FSH activity. Partially deglycosylated eCG (eCG
56/ß) also stimulated estradiol production, confirming that the FSH-like activity of eCG is resistant to the removal of the N-linked oligosaccharide. Partially deglycosylated eFSH (eFSH
56/ß), however, did not show any FSH activity, indicating that the oligosaccharide at Asn56 was necessary for eFSH. Thus, FSH-like activities of two gonadotropins, eCG and eFSH, are evoked through the distinct molecular mechanisms regarding the biological role of oligosaccharide at Asn56 of the
subunit.
FSH, hormone action
| INTRODUCTION |
|---|
|
|
|---|
and ß subunits that are specific for each hormone [1]. As an exception, ß subunits of equine CG (eCG) and LH (eLH) are encoded by a common single gene, and share an identical amino acid sequence [2]. We have previously cloned cDNAs for the
subunit of equine glycoprotein hormones and eCG/LH ß subunits, and confirmed the expression of mRNAs for eCG
and ß subunits in the placenta [3]. We have also showed that the recombinant eCG/LH has potent LH- and FSH-like activities [4].
A combination of these subunits is essential for the expression of their biological activity [1]. The
subunit has two possible N-linked glycosylation sites, which are located at positions 56 and 82 in domestic and laboratory animals, including the horse, and at 52 and 78 in human [3, 5]. The ß subunits have either one (in LH and CG) or two (in FSH) possible N-glycosylation sites [1]. Removal of the N-linked oligosaccharides from gonadotropins by either an enzymatic or a chemical method has been shown to reduce their adenylate cyclase-stimulating activities, suggesting that, in general, N-linked oligosaccharides are required for the biological function of gonadotropins [68]. Site-directed mutagenesis of human CG has revealed that the N-linked oligosaccharide at Asn52 of human
subunit is essential for its biological activity [9]. We have analyzed the activity of partially deglycosylated recombinant eCG mutant, and demonstrated that the oligosaccharide at Asn56 of the
subunit of eCG/LH plays an indispensable role in LH-like activity [4]. Similarly, an N-linked oligosaccharide at the same position of human FSH appeared to be necessary to express its biological activity [10, 11]. Therefore, an N-linked glycosylation site at Asn52 or Asn56 of the
subunit is functionally important for biological activity.
One important finding was that the FSH-like activity was not reduced in the partially deglycosylated mutant of eCG in which Asn56 of the
subunit was substituted by Gln (eCG
56/ß) [4], indicating that the FSH-like activity of eCG is resistant to removal of the N-linked oligosaccharide. These unique characteristics of equine gonadotropins raise the possibility that eFSH may also have characteristics that are distinct from those of other mammalian species. A cDNA encoding the eFSH ß subunit, however, has not been cloned, so that the biological activity of the recombinant hormone has never been evaluated.
In the present study, we cloned the eFSH ß subunit cDNA and characterized the biological role of the N-linked oligosaccharide at Asn56 of the
subunit by preparing partially deglycosylated mutant eFSH (eFSH
56/ß).
| MATERIALS AND METHODS |
|---|
|
|
|---|
The expression vector, pABWN, was generously provided by Dr. J.I. Miyazaki (Osaka University, Japan). CHO-K1 cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). Endonucleases and the Random Primer DNA Labeling Kit were purchased from Takara Shuzo (Kyoto, Japan). Polymerase chain reaction (PCR) reagents were from Stratagene (La Jolla, CA). Trizol reagent, the Superscript preamplification system, Ham F-12, and lipofectamine were from Gibco BRL (Gaithersburg, MD). Fetal bovine serum was from Hyclone Laboratories (Logan, UT). BSA and insulin were from Sigma Chemical Company (St. Louis, MO). Diethylstilbestrol was from Nacalai Tesque Inc. (Kyoto, Japan). Synthetic oligonucleotide primers were purchased from Grainer Japan (Tokyo, Japan). All other reagents used were from Wako Pure Chemicals (Osaka, Japan) unless otherwise noted.
Hormones
Purified human CG (CR-127), human FSH (AFP-5614E), and polyclonal anti-human FSH ß subunit antiserum (AFP 1) were obtained from the National Hormone and Pituitary Program of the National Institute for Diabetes and Digestive and Kidney Diseases (Bethesda, MD). Anti-human FSH (M91) was from Endocrine Services Ltd (Warwickshire, U.K.). Highly purified eFSH (E219B) was kindly provided by Dr. Papkoff (University of California, Davis, CA).
Isolation of RNA
Equine pituitary tissue was obtained from a male horse (27 mo old) that was killed at the Equine Research Institute, Japan Racing Association, by intravenous injection of a mixture of sodium thiopental (Ravonal; Tanabe Pharmaceutical, Osaka, Japan) and suxamethonium chloride solution (Succine; Yamanouchi Pharmaceutical, Osaka, Japan) followed immediately by severing the carotid arteries. The tissue was kept at -80°C until extraction of RNA. Total RNA was extracted according to the method previously described elsewhere [4].
PCR Amplification
First-strand cDNA was synthesized by using the Superscript preamplification system according to the manufacturer's instructions. The primers for the eFSH ß subunit (degenerate sense primer, 5'-CCA GGA TGA AGT CNG TCC AGT-3'; antisense primer, 5'-GTA CAC ACA GAC ATC TTG GAT-3') were designed based on the conserved nucleotide sequences between human [12, 13], rat [14], and bovine [15, 16] FSH ß subunits. The amplified products were ligated into the SmaI site of pUC119. Sequence data were analyzed with MacMollyTetra computer software (Soft Gene, Berlin, Germany).
Construction of the Expression Vector, and Transfection and Cloning of the Stable Transformants
Point mutations were introduced by PCR strategies, and the sequence of the entire region of mutated cDNA was verified by automated DNA sequencing as previously reported [4]. The wild-type (eFSH
/ß) and mutant (eFSH
56/ß) cDNAs were subcloned into the modified eukaryotic expression vector pABWN (designated as pABeFSH
/ß and pABeFSH
56/ß, respectively) for transfection, as described previously [4]. The pABWN (11 kilobase [kb]) consists of a promoter based on the chicken ß-actin promoter and a 69% subregion of the bovine papillomavirus genome [17]. Stable transformants were obtained after G418 selection and cloning as described previously [4]. Briefly, CHO cells plated in 60-mm dishes were transfected at 70%80% confluency with 5 µg of each plasmid by means of Lipofectamine. Six to eight pools of stably transfected cells expressing wild-type and mutant cDNAs were selected for G418 resistance.
Hormone Quantitation
The cell lines were cultured for 48 h in serum-free medium. The medium was collected, clarified by centrifugation, and concentrated in an Amicon stirred cell concentrator (Amicon Corp., Danvers, MA). The amount of recombinant eFSH was estimated by radioimmunoassay with purified eFSH (E219B) used as reference standard as previously described [4, 18].
In Vitro Bioassay
The biological activities of recombinant eFSHs were assayed based on the measurement of estradiol production in the rat granulosa cell culture system and testosterone production in the rat Leydig cell culture system for FSH-like and LH-like activities, respectively, as described previously [4].
| RESULTS |
|---|
|
|
|---|
By using the cDNA prepared from mRNA extracted from equine pituitary tissue and the degenerated primers, PCR was performed to isolate eFSH ß subunit cDNA. The amplified fragment of expected size (462 base pairs [bp]) was cloned and sequenced. The nucleotide sequence and deduced amino acid sequence of the isolated eFSH ß subunit are shown in Figure 1A. The position of the first amino acid of mature eFSH ß subunit was predicted by comparison to the known amino acid sequence of the equine hormone determined previously by protein sequencing [19]. Sequence data analysis showed that the cDNA encoded the eFSH ß subunit including the signal peptide region, consisting of 18 amino acids, and mature protein of 111 amino acids. As shown in Figure 1B, eFSH ß subunit was very similar to that of the other species: homologies of nucleotide sequence between the eFSH ß subunit and bovine [16], human [12, 13], rat [14], porcine [20], and ovine [21] are 92.7%, 93.2%, 87.7%, 95.0%, and 91.9%, respectively. Two possible N-glycosylation sites, Asn7 and Asn24, and 12 cysteine residues forming intramolecular disulfide bonds were conserved in the eFSH ß subunit as in those of other species. Northern hybridization analysis, by using the cloned fragment of eFSH ß subunit cDNA as a probe, revealed the band of approximately 1.8 kb in size in equine pituitary RNA (data not shown).
|
Biological Activities of the Recombinant eFSHs
To investigate the biological activity of eFSH, we prepared wild-type and mutant
subunits that lack one of the possible N-linked oligosaccharide sites, Asn56 (Fig. 2, A and B) [4]. The FSH activity evaluated by the stimulation of estradiol production from the primary culture of granulosa cells increased in direct proportion to the concentration of human FSH added to the culture medium (Fig. 3A). Wild-type eFSH (eFSH
/ß; Fig. 2A) also had a dose-response curve very similar to that of human FSH (Fig. 3A). The LH-like activity evaluated by the stimulation of testosterone production from Leydig cells increased in direct proportion to the concentration of hCG (Fig. 3C). In contrast, the response to eFSH
/ß was almost completely flat (Fig. 3C). The recombinant eFSH therefore exhibits potent FSH activity but has negligible LH-like activity in the assay system examined. Biological activities of partially deglycosylated eFSH (eFSH
56/ß; Fig. 2A) were evaluated and compared with those of recombinant eCG (eCG
/ß; Fig. 2A). Wild-type eCG showed dual LH-like and FSH-like activities (Fig. 3, B and D), and partially deglycosylated eCG (eCG
56/ß) also strongly stimulated estradiol production (Fig. 3B). The LH-like potency of eCG
56/ß, however, was calculated as approximately 10-fold lower than that of eCG
/ß (Fig. 3D, Table 1), confirming the results of the previous study, which showed that deglycosylation at Asn56 of the
subunit caused a selective decrease in LH-like activity but not in the FSH-like activity of eCG [4]. In contrast, the dose-response curve of estradiol production and of testosterone production by eFSH
56/ß was completely flat (Fig. 3, A and C). Therefore, the mutant eFSH showed neither FSH-like or LH-like activity. These results demonstrated that the oligosaccharide attached to Asn56 of the
subunit is indispensable for the biological activities of eFSH.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
subunit of ovine and human gonadotropins [6, 8, 26] play a more important role in signal transduction than those on the corresponding ß subunits. And by means of site-directed mutagenesis it has been shown that N-linked oligosaccharide chains on the
subunit at position 52 are important for hCG and human FSH signal transduction [9, 10]. In the present study we confirmed our previous finding that recombinant eCG has both LH-like and FSH-like activities [4]. In addition, we demonstrated that recombinant eFSH has FSH activity. It is therefore now clear that eFSH, eLH, and eCG have FSH activity, as was proposed previously [5, 27]. It is interesting that FSH activity was not observed in eFSH
56/ß, but that of eCG
56/ß maintained at the level comparable to the wild-type eCG, indicating that the N-linked oligosaccharide attached to Asn56 of the
subunit of eFSH is necessary for eFSH to express biological activity. This indispensable role of the N-linked oligosaccharide was believed to be common to human FSH [10, 11]. Therefore, the biological roles of N-linked oligosaccharides on the
subunit are different in eFSH and eCG in their FSH activity. FSH-like activity of eCG is quite unique and the function of N-linked oligosaccharide in eCG seems to be distinct from that of eFSH, human FSH, and hCG. In conclusion, we cloned the cDNA of the eFSH ß subunit and clarified that both recombinant eCG and eFSH have FSH activity. The FSH-like activities of these two gonadotropins, eCG and eFSH, are evoked through the distinct molecular mechanisms regarding the biological role of oligosaccharide at Asn56 of the
subunit.
| FOOTNOTES |
|---|
1 This work was supported in part by the Program for Promotion of Basic Research Activities for Innovative Biosciences, by the Research for the Future Program, The Japan Society for the Promotion of Science (JSPS-RFTF97L00904), and by a Grants-in-Aid for Scientific Research, Ministry of Education, Science and Culture, Japan (11794010). ![]()
2 Correspondence: Kunio Shiota, Laboratory of Cellular Biochemistry, Animal Resource Sciences/Veterinary Medical Sciences, University of Tokyo, 111 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. FAX: 81 3 5841 8189; ashiota{at}mail.ecc.u-tokyo.ac.jp ![]()
Accepted: July 5, 2001.
Received: December 13, 2000.
| REFERENCES |
|---|
|
|
|---|
-subunit cDNA and its expression in the equine placenta. J Reprod Dev 1994; 40:301-305
-subunit. J Endocrinol 1987; 115:341-346[Abstract]
subunit in transduction of biological signal in glycoprotein hormones. Science 1985; 229:65-67
, ßA, and ßB subunits in the ovary. Biol Reprod 1998; 59:1392-1398
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |